Cargando…
Retraction Note to: LATS2 overexpression attenuates the therapeutic resistance of liver cancer HepG2 cells to sorafenib‑mediated death via inhibiting the AMPK–Mfn2 signaling pathway
Autores principales: | Song, Jie, Zhao, Wei, Lu, Chang, Shao, Xue |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6936120/ https://www.ncbi.nlm.nih.gov/pubmed/31892858 http://dx.doi.org/10.1186/s12935-019-1084-7 |
Ejemplares similares
-
LATS2 overexpression attenuates the therapeutic resistance of liver cancer HepG2 cells to sorafenib-mediated death via inhibiting the AMPK–Mfn2 signaling pathway
por: Song, Jie, et al.
Publicado: (2019) -
Retraction Note: The nuclear orphan receptor Nur77 alleviates palmitate-induced fat accumulation by down-regulating G0S2 in HepG2 cells
por: Zhao, Naiqian, et al.
Publicado: (2022) -
Retraction Note: The novel long non-coding RNA LATS2-AS1-001 inhibits gastric cancer progression by regulating the LATS2/YAP1 signaling pathway via binding to EZH2
por: Sun, Dan, et al.
Publicado: (2022) -
Retraction Note: BMP2 secretion from hepatocellular carcinoma cell HepG2 enhances angiogenesis and tumor growth in endothelial cells via activation of the MAPK/p38 signaling pathway
por: Feng, Peng-Cheng, et al.
Publicado: (2022) -
Retraction Note: Inhibition of microRNA-214 promotes epithelial–mesenchymal transition process and induces interstitial cystitis in postmenopausal women by upregulating Mfn2
por: Lv, Jian-Wei, et al.
Publicado: (2022)